Resources

Despite its proven impact and strong continental commitments, immunization in Africa is increasingly under threat—jeopardizing hard-won progress and putting millions at risk.At PATH, we believe that taking action now will not only protect hard-won gains but also push the continent closer to achieving global immunization goals and securing a healthier future for all.In this brief, we highlight four priority action areas essential for sustaining and driving immunization progress: strengthening political commitment and accountability, increasing domestic health investments, promoting African vaccine manufacturing, and enhancing coordinated, evidence-based communication.This resource is intended for advocates, technical decision-makers, policymakers, and anyone interested in learning about key immunization advocacy priorities necessary to advance immunization equity in Africa.

This document provides a historical overview and current status of technologies that support injection safety such as autodisable (AD) syringes, reuse prevention syringes (RUP), sharps injury prevention (SIP) syringes, disposable-syringe jet injectors, and compact prefilled autodisable (CPAD). It documents the global progress over the past two decades that have led to a significant reduction in bloodborne pathogen transmission and the continued efforts needed to sustain the gains that have been made and to eliminate disease transmission from needlestick injuries and misuse of syringes.Current version published November 2025, replacing 2021 version.

A summary of how philanthropic donors powered PATH's work in 2024.

A short, community-focused guide developed by PATH and partners to raise awareness about the importance of medical oxygen. It explains what medical oxygen is, why it's vital for saving lives, and how it is used to treat conditions such as pneumonia, complications after childbirth, and COVID-19. The document highlights Zambia's efforts to expand oxygen access through the national plan, training of health workers, and investments in production and maintenance systems. It also corrects common myths and misconceptions about oxygen use, emphasizing that oxygen is safe, effective, and essential for quality health care.

The World Health Organization-recommended single-dose schedule for human papillomavirus (HPV) vaccination is expected to bring operational efficiencies and lower costs to country immunization programs. PATH conducted a study on behalf of the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium to obtain insights into how switching to a single-dose schedule has impacted HPV vaccination programs in low- and middle-income countries and to gather insights for ongoing program planning and sustainability with a single-dose schedule. PATH conducted 35 semi-structured key informant interviews with national and subnational stakeholders in Burkina Faso, Ethiopia, and Solomon Islands to explore the operational aspects of switching from a two-dose to a one-dose HPV vaccination schedule across key thematic areas of the immunization program. This report shares high-level results from the study.